Matching slides 60,557
Current window 46,051-46,080
Pages 2,019
Rows per page 30
Component: Tableclear collectionreset all

Component

46,051-46,080 of 60,557

filter-aware
32
Contains four distinct sub-tables detailing investment components, performance fee receivables, and gross/net invested assets.Apollo Global Management | Results Presentation Deck | 40 slides · Apollo Global Management
Conference presentation Investor relations Beat · Financials1 hit
33
The table shows adjustments for investment gains/losses, insurance liabilities, integration expenses, stock compensation, and non-controlling interests.Apollo Global Management | Results Presentation Deck | 40 slides · Apollo Global Management
Conference presentation Investor relations Beat · Financials1 hit
04
The slide uses a matrix-like layout to organize drug assets by therapeutic area and development stage (approved vs. pipeline).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem1 hit
09
The slide uses a grid-based layout to organize drug candidates by development stage. It includes a legend for '# Partnered and/or in collaboration' and a yellow dot for 'Precision medicine approach being explored'.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
14
The slide uses a color-coded sidebar to indicate the development stage of the drug across different therapeutic areas.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide provides a detailed overview of seven specific clinical trials (AEGEAN, ADJUVANT BR.31, PACIFIC-4, PACIFIC-5, PACIFIC-8, ADRIATIC, PACIFIC-9).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
The slide uses a standard clinical trial registry format.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide is part of an appendix, providing detailed clinical trial data for Imfinzi.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The slide uses a standard clinical trial registry format.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
The slide is part of an appendix section detailing clinical trial status for specific drug assets.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
20
The slide is part of an appendix, likely from a pharmaceutical investor presentation.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
21
The slide uses a vertical tab structure on the right to categorize the therapeutic area (Oncology).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
22
The slide provides a structured overview of three specific clinical trials: DESTINY-Gastric04, 06, and 03.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
23
The slide is part of an appendix, indicated by the footer and the 'Other' tab in the right-hand navigation.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
24
The slide uses a standard clinical trial pipeline table format.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
25
The slide uses a standard clinical trial registry format for reporting pipeline progress.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
26
The slide uses a standard clinical trial registry format for portfolio tracking.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
27
The slide is part of an appendix, specifically detailing clinical trial status for a specific drug.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
28
The slide provides a structured overview of four specific clinical trials (LAURA, ADAURA2, NeoADAURA, FLAURA2).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
29
The slide provides a structured overview of five specific clinical trials (SAFFRON, SANOVO, SACHI, SAVANNAH, ORCHARD) including patient counts and trial arms.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
30
The slide uses a color-coded sidebar on the right to categorize the drug's development stage (Oncology).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
05
The slide uses a combination of a metric table and a stacked bar chart to illustrate growth.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
10
The slide includes a navigation bar at the top and a footer with footnotes and page number.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
11
Includes footnotes regarding rounding, CER (Constant Exchange Rate), and specific exclusions for Product Sales Gross Margin.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
16
Slide 16 of a presentation deck. Includes a legend for established SoC vs ongoing trials.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Loop · Voice Of Customer1 hit
29
AstraZeneca | Results Presentation Deck | 38 slidesAstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
31
The slide uses a grid layout to categorize clinical trials (e.g., DESTINY-Breast, TROPION-Breast) against patient segments and treatment lines.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
35
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
36
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
38
Data presented as stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit